Geode Capital Management’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Buy |
972,921
+70,935
| +8% | +$805K | ﹤0.01% | 2298 |
|
|
2025
Q1 | $6M | Buy |
901,986
+24,891
| +3% | +$166K | ﹤0.01% | 2572 |
|
|
2024
Q4 | $9.68M | Buy |
877,095
+6,264
| +0.7% | +$69.1K | ﹤0.01% | 2401 |
|
|
2024
Q3 | $10.7M | Buy |
870,831
+76,661
| +10% | +$942K | ﹤0.01% | 2337 |
|
|
2024
Q2 | $10.7M | Buy |
794,170
+154,363
| +24% | +$2.09M | ﹤0.01% | 2280 |
|
|
2024
Q1 | $8.64M | Buy |
639,807
+24,083
| +4% | +$325K | ﹤0.01% | 2409 |
|
|
2023
Q4 | $3.24M | Buy |
615,724
+24,607
| +4% | +$129K | ﹤0.01% | 2911 |
|
|
2023
Q3 | $2.33M | Sell |
591,117
-8,663
| -1% | -$34.1K | ﹤0.01% | 3023 |
|
|
2023
Q2 | $6.38M | Buy |
599,780
+113,100
| +23% | +$1.2M | ﹤0.01% | 2560 |
|
|
2023
Q1 | $4.05M | Buy |
486,680
+12,456
| +3% | +$104K | ﹤0.01% | 2729 |
|
|
2022
Q4 | $4.38M | Buy |
474,224
+13,969
| +3% | +$129K | ﹤0.01% | 2734 |
|
|
2022
Q3 | $5.91M | Buy |
460,255
+16,446
| +4% | +$211K | ﹤0.01% | 2580 |
|
|
2022
Q2 | $5.86M | Buy |
443,809
+8,038
| +2% | +$106K | ﹤0.01% | 2613 |
|
|
2022
Q1 | $9.17M | Buy |
435,771
+59,617
| +16% | +$1.25M | ﹤0.01% | 2405 |
|
|
2021
Q4 | $9.02M | Buy |
376,154
+12,819
| +4% | +$307K | ﹤0.01% | 2517 |
|
|
2021
Q3 | $9.24M | Buy |
363,335
+7,089
| +2% | +$180K | ﹤0.01% | 2501 |
|
|
2021
Q2 | $12M | Buy |
356,246
+63,210
| +22% | +$2.13M | ﹤0.01% | 2334 |
|
|
2021
Q1 | $11.4M | Buy |
293,036
+21,871
| +8% | +$849K | ﹤0.01% | 2271 |
|
|
2020
Q4 | $16.8M | Buy |
271,165
+68,976
| +34% | +$4.27M | ﹤0.01% | 1830 |
|
|
2020
Q3 | $6.77M | Buy |
202,189
+42,245
| +26% | +$1.41M | ﹤0.01% | 2211 |
|
|
2020
Q2 | $3.81M | Sell |
159,944
-25,912
| -14% | -$617K | ﹤0.01% | 2495 |
|
|
2020
Q1 | $4.26M | Buy |
185,856
+66,139
| +55% | +$1.51M | ﹤0.01% | 2235 |
|
|
2019
Q4 | $3.39M | Buy |
119,717
+6,965
| +6% | +$197K | ﹤0.01% | 2686 |
|
|
2019
Q3 | $2.42M | Buy |
+112,752
| New | +$2.42M | ﹤0.01% | 2820 |
|